BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27561800)

  • 21. Treatment of patients excluded from Eastern Cooperative Oncology Group 4599 and AVAiL studies: focus on brain metastasis and squamous histology.
    Morgensztern D; Govindan R
    Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S57-61. PubMed ID: 21885000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Halasz LM; Uno H; Hughes M; D'Amico T; Dexter EU; Edge SB; Hayman JA; Niland JC; Otterson GA; Pisters KM; Theriault R; Weeks JC; Punglia RS
    Cancer; 2016 Jul; 122(13):2091-100. PubMed ID: 27088755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.
    Lukas RV; Kumthekar P; Rizvi S; Salgia R
    Future Oncol; 2016; 12(8):1045-58. PubMed ID: 26888310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of brain metastases from lung cancer: chemotherapy.
    Schuette W
    Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study.
    Chabot P; Hsia TC; Ryu JS; Gorbunova V; Belda-Iniesta C; Ball D; Kio E; Mehta M; Papp K; Qin Q; Qian J; Holen KD; Giranda V; Suh JH
    J Neurooncol; 2017 Jan; 131(1):105-115. PubMed ID: 27655223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stereotactic radiation therapy for non small cell lung cancer].
    Uematsu M
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):256-7. PubMed ID: 11904990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain metastases in non-small-cell lung cancer.
    Dawe DE; Greenspoon JN; Ellis PM
    Clin Lung Cancer; 2014 Jul; 15(4):249-57. PubMed ID: 24954227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study.
    Moro-Sibilot D; Smit E; de Castro CarpeƱo J; Lesniewski-Kmak K; Aerts JG; Villatoro R; Kraaij K; Nacerddine K; Dyachkova Y; Smith KT; Girvan A; Visseren-Grul C; Schnabel PA
    Lung Cancer; 2015 Dec; 90(3):427-32. PubMed ID: 26791802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
    Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.
    Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M
    Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
    Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
    J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metastases in small cell lung cancer.
    Quan AL; Videtic GM; Suh JH
    Oncology (Williston Park); 2004 Jul; 18(8):961-72; discussion 974, 979-80, 987. PubMed ID: 15328892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer.
    Hainsworth JD; Fang L; Huang JE; Karlin D; Russell K; Faoro L; Azzoli C
    J Thorac Oncol; 2011 Jan; 6(1):109-14. PubMed ID: 21107290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.
    McGranahan T; Nagpal S
    Curr Treat Options Oncol; 2017 Apr; 18(4):22. PubMed ID: 28391420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.
    Schuler M; Wu YL; Hirsh V; O'Byrne K; Yamamoto N; Mok T; Popat S; Sequist LV; Massey D; Zazulina V; Yang JC
    J Thorac Oncol; 2016 Mar; 11(3):380-90. PubMed ID: 26823294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
    Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodality management of non-small cell lung cancer patients with brain metastases.
    Ricciardi S; de Marinis F
    Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frontline Systemic Therapy With Pemetrexed-Platinum in Nonsquamous Non-Small-Cell Lung Cancer With Asymptomatic Brain Metastases.
    Alsidawi S; Chaudhary R; Karim NA
    Am J Ther; 2017; 24(2):e111-e120. PubMed ID: 25153672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.